Controlled and/or prolonged parental delivery of peptides from the hypothalmic pituitary axis
- 30 April 1997
- journal article
- review article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 43 (2), 115-131
- https://doi.org/10.1016/s0939-6411(96)00030-6
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Short‐term cardiovascular effects of somatostatin in patients with cirrhosisLiver International, 1995
- Effect of Thyrotropin-releasing Hormone on Pentobarbitone-induced Sleep in Rats: Continuous Treatment with a Sustained Release Injectable FormulationJournal of Pharmacy and Pharmacology, 1993
- Drug delivery systems and routes of administration of peptide and protein drugsEuropean Journal of Drug Metabolism and Pharmacokinetics, 1990
- NafarelinDrugs, 1990
- In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers.CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
- Comparisons of the Potential Utility of LHRH Agonists and Antagonists for Fertility ControlJournal of Steroid Biochemistry, 1985
- Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system.BMJ, 1984
- Controlled-Release Delivery Systems for Hormones A Review of their Properties and Current Therapeutic UseDrugs, 1984
- Induction of Puberty in Men by Long-Term Pulsatile Administration of Low-Dose Gonadotropin-Releasing HormoneNew England Journal of Medicine, 1982
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982